22 devices · GMDN 57184
This category includes in vitro diagnostic devices that use antibodies to detect epidermal growth factor receptor (EGFR) in clinical specimens. These devices are designed for qualitative or quantitative measurement of EGFR, a protein often assessed to guide cancer diagnosis and treatment decisions.
Devices in this category are regulated as in vitro diagnostics and rely on antibody-antigen binding for their function. They are supplied as reagents or test systems intended for use in laboratory settings to support clinical evaluation of EGFR expression.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.